Overcoming barriers by local drug delivery with liposomes

被引:204
作者
Antimisiaris, S. G. [1 ,2 ]
Marazioti, A. [1 ]
Kannavou, M. [1 ,2 ]
Natsaridis, E. [1 ,2 ]
Gkartziou, F. [2 ]
Kogkos, G. [1 ,2 ]
Mourtas, S. [1 ]
机构
[1] Univ Patras, Sch Hlth Sci, Dept Pharm, Lab Pharmaceut Technol, Rion 26504, Greece
[2] Fdn Res & Technol Hellas FORTH ICES, Inst Chem Engn Sci, Rion 26504, Greece
关键词
Liposomes; Drug; Topical routes; Local delivery; Administration; Ocular; Pulmonary; Nasal; Oral; Intratumoral; Vaginal; Vaccine; COVID-19; BLOOD-BRAIN-BARRIER; SURFACE-MODIFIED LIPOSOMES; IN-VITRO CHARACTERIZATION; SUSTAINED-RELEASE; TRANSDERMAL DELIVERY; CATIONIC LIPOSOMES; LOADED LIPOSOMES; OCULAR DELIVERY; DRY POWDER; BIOLOGICAL BARRIERS;
D O I
10.1016/j.addr.2021.01.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Localized or topical administration of drugs may be considered as a potential approach for overcoming the problems caused by the various biological barriers encountered in drug delivery. The combination of using localized administration routes and delivering drugs in nanoparticulate formulations, such as liposomes, may have additional advantages. Such advantages include prolonged retention of high drug loads at the site of action and controlled release of the drug, ensuring prolonged therapeutic effect; decreased potential for side-effects and toxicity (due to the high topical concentrations of drugs); and increased protection of drugs from possible harsh environments at the site of action. The use of targeted liposomal formulations may further potentiate any acquired therapeutic advantages. In this review we present the most advanced cases of localized delivery of liposomal formulations of drugs, which have been investigated pre-clinically and clinically in the last ten years, together with the reported therapeutic advantages, in each case. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 86
页数:34
相关论文
共 263 条
  • [1] Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation
    Abd El-Alim, Sameh Hosam
    Kassem, Ahmed Alaa
    Basha, Mona
    Salama, Abeer
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 563 : 293 - 303
  • [2] Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
    Abdelaziz, Hadeer M.
    Gaber, Mohamed
    Abd-Elwakil, Mahmoud M.
    Mabrouk, Moustafa T.
    Elgohary, Mayada M.
    Kamel, Nayra M.
    Kabary, Dalia M.
    Freag, May S.
    Samaha, Magda W.
    Mortada, Sana M.
    Elkhodairy, Kadria A.
    Fang, Jia-You
    Elzoghby, Ahmed O.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 269 : 374 - 392
  • [3] Formulation and Characterization of Sertaconazole Nitrate Mucoadhesive Liposomes for Vaginal Candidiasis
    Abdellatif, Menna M.
    Khalil, Islam A.
    Elakkad, Yara E.
    Eliwa, Hesham A.
    Samir, Tamer M.
    Al-Mokaddem, Asmaa K.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 4079 - 4090
  • [4] Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model
    Abu Lila, Amr S.
    Kato, Chihiro
    Fukushima, Masakazu
    Huang, Cheng-Long
    Wada, Hiromi
    Ishida, Tatsuhiro
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (04) : 1399 - 1407
  • [5] Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment
    Acar, Duygu
    Teresa Molina-Martinez, Irene
    Gomez-Ballesteros, Miguel
    Guzman-Navarro, Manuel
    Manuel Benitez-del-Castillo, Jose
    Herrero-Vanrell, Rocio
    [J]. CONTACT LENS & ANTERIOR EYE, 2018, 41 (01) : 93 - 96
  • [6] Targeting Macromolecules to CNS and Other Hard-to-Treat Organs Using Lectin-Mediated Delivery
    Acosta, Walter
    Cramer, Carole L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [7] Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment
    Adnet, Thomas
    Groo, Anne-Claire
    Picard, Celine
    Davis, Audrey
    Corvaisier, Sophie
    Since, Marc
    Bounoure, Frederic
    Rochais, Christophe
    Le Pluart, Loic
    Dallemagne, Patrick
    Malzert-Freon, Aurelie
    [J]. PHARMACEUTICS, 2020, 12 (03)
  • [8] Agrawal M., 2020, J CONTROL RELEASE, V321, P372, DOI [10.1016/j.jconrel.2020.02.020, DOI 10.1016/J.JC0NREL.2020.02]
  • [9] Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
    Agrawal, Mukta
    Saraf, Shailendra
    Saraf, Swarnlata
    Dubey, Sunil K.
    Puri, Anu
    Gupta, Umesh
    Kesharwani, Prashant
    Ravichandiran, V
    Kumar, Pramod
    Naidu, V. G. M.
    Murty, Upadhyayula Suryanarayana
    Ajazuddin
    Alexander, Amit
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 327 : 235 - 265
  • [10] Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
    Agrawal, Mukta
    Saraf, Swarnlata
    Saraf, Shailendra
    Antimisiaris, Sophia G.
    Chougule, Mahavir Bhupal
    Shoyele, Sunday A.
    Alexander, Amit
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 281 : 139 - 177